T. Gagliano-Juca
Institute of Biophysics Carlos Chagas Filho/UFRJ, CCS-Bloco G, 21949-900, Rio de Janeiro, RJ, Brazil
A.M.M. Arruda
Galeno Research Unit, Latino Coelho St., 1301, Parquel Taquaral, 13087-010, Campinas, SP, Brazil
M.F. Sampaio
Galeno Research Unit, Latino Coelho St., 1301, Parquel Taquaral, 13087-010, Campinas, SP, Brazil
A.G. Lopes
Institute of Biophysics Carlos Chagas Filho/UFRJ, CCS-Bloco G, 21949-900, Rio de Janeiro, RJ, Brazil
G. De Nucci
Department of Pharmacology, ICB-USP, 05508-900, Sao Paulo, SP, Brazil
PDF Fulltext XML References Citation
How to cite this article
T. Gagliano-Juca, A.M.M. Arruda, M.F. Sampaio, A.G. Lopes and G. De Nucci, 2014. Phase I Study of the Novel Antifungal Agent Dapaconazole (Zilt®)
in Healthy Volunteers. International Journal of Pharmacology, 10: 507-512.
DOI: 10.3923/ijp.2014.507.512
URL: https://scialert.net/abstract/?doi=ijp.2014.507.512
DOI: 10.3923/ijp.2014.507.512
URL: https://scialert.net/abstract/?doi=ijp.2014.507.512